Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation of the BRADA and ABILHAND Questionnaires

This study has been completed.
Roche Pharma AG
Information provided by:
University Hospital, Ghent Identifier:
First received: July 10, 2009
Last updated: July 13, 2011
Last verified: July 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
No publications provided by University Hospital, Ghent

Publications automatically indexed to this study by Identifier (NCT Number):